Ernexa Therapeutics Inc. Accrued Rent, Current
Ernexa Therapeutics Inc. (ERNA) had Accrued Rent, Current of $2.30 million as of 2024-05-03, per its 10-K filed 2025-03-12.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRentCurrent · last filed 2025-03-12
- 2024-05-03: Accrued Rent, Current $2.30M.
| Period end | Accrued Rent, Current |
|---|---|
| 2024-05-03 | $2.30M 10-K · filed 2025-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |